BACKGROUND: Diabetic patients have a worse prognosis than nondiabetic patients after myocardial infarction. Although exercise improves risk factors, exercise capacity, and mortality, it is still unclear if these benefits are the same as in nondiabetics. Furthermore, although exercise tolerance is predicted by systolic and diastolic dysfunction in nondiabetics, its role as a predictor of exercise capacity in diabetics remains unclear. HYPOTHESIS: Diabetics and nondiabetics see a similar improvement in their cardiac risk factors and exercise parameters from exercise-based cardiac rehabilitation (CR). METHODS: A series of 370 diabetics and 942 nondiabetics entered a 36-session outpatient CR program after interventions for coronary heart disease or after bypass or cardiac valve surgery. The program consisted of physical exercise, lifestyle modification, and pharmacotherapy. RESULTS: Quality of life, weight, blood pressure, and lipid profiles improved significantly in both groups during the 12-week program. Baseline metabolic equivalents (METs) were lower in diabetics vs nondiabetics at the start of CR (2.4 vs 2.7, P < 0.001). Although both groups increased their exercise capacity, diabetics had less improvement (change in METs 1.7 vs 2.6, P < 0.001). Significant predictors for improvement after CR included age, sex, and weight, as well as both systolic and diastolic function. After adjustment for these, diabetes remained a significant predictor of reduced improvement in exercise capacity. CONCLUSIONS: Diabetics saw a significant benefit in quality of life, weight, exercise tolerance, and cardiac risk factors, but to a lesser extent when compared with nondiabetics. The mechanisms for poorer improvement in diabetics following CR also include noncardiac factors and require further study.
BACKGROUND:Diabeticpatients have a worse prognosis than nondiabeticpatients after myocardial infarction. Although exercise improves risk factors, exercise capacity, and mortality, it is still unclear if these benefits are the same as in nondiabetics. Furthermore, although exercise tolerance is predicted by systolic and diastolic dysfunction in nondiabetics, its role as a predictor of exercise capacity in diabetics remains unclear. HYPOTHESIS: Diabetics and nondiabetics see a similar improvement in their cardiac risk factors and exercise parameters from exercise-based cardiac rehabilitation (CR). METHODS: A series of 370 diabetics and 942 nondiabetics entered a 36-session outpatient CR program after interventions for coronary heart disease or after bypass or cardiac valve surgery. The program consisted of physical exercise, lifestyle modification, and pharmacotherapy. RESULTS: Quality of life, weight, blood pressure, and lipid profiles improved significantly in both groups during the 12-week program. Baseline metabolic equivalents (METs) were lower in diabetics vs nondiabetics at the start of CR (2.4 vs 2.7, P < 0.001). Although both groups increased their exercise capacity, diabetics had less improvement (change in METs 1.7 vs 2.6, P < 0.001). Significant predictors for improvement after CR included age, sex, and weight, as well as both systolic and diastolic function. After adjustment for these, diabetes remained a significant predictor of reduced improvement in exercise capacity. CONCLUSIONS:Diabetics saw a significant benefit in quality of life, weight, exercise tolerance, and cardiac risk factors, but to a lesser extent when compared with nondiabetics. The mechanisms for poorer improvement in diabetics following CR also include noncardiac factors and require further study.
Authors: Marni J Armstrong; Ronald J Sigal; Ross Arena; Trina L Hauer; Leslie D Austford; Sandeep Aggarwal; James A Stone; Billie-Jean Martin Journal: Diabetologia Date: 2015-01-26 Impact factor: 10.122
Authors: Deepika R Laddu; Cemal Ozemek; Trina L Hauer; Codie R Rouleau; Tavis S Campbell; Stephen B Wilton; Sandeep Aggarwal; Leslie Austford; Ross Arena Journal: Int J Cardiol Date: 2019-11-26 Impact factor: 4.164
Authors: Birgitte Bitsch Gadager; Lars Hermann Tang; Maiken Bay Ravn; Patrick Doherty; Alexander Harrison; Jan Christensen; Rod S Taylor; Ann-Dorthe Zwisler; Thomas Maribo Journal: BMC Cardiovasc Disord Date: 2022-06-27 Impact factor: 2.174
Authors: Timothy J Roberts; Andrew T Burns; Richard J MacIsaac; Andrew I MacIsaac; David L Prior; André La Gerche Journal: Cardiovasc Diabetol Date: 2018-03-23 Impact factor: 9.951
Authors: Hélène De Cannière; Christophe J P Smeets; Melanie Schoutteten; Carolina Varon; John F Morales Tellez; Chris Van Hoof; Sabine Van Huffel; Willemijn Groenendaal; Pieter Vandervoort Journal: J Clin Med Date: 2020-09-29 Impact factor: 4.964
Authors: Manuel F Jiménez-Navarro; Francisco Lopez-Jimenez; Luis M Pérez-Belmonte; Ryan J Lennon; Carlos Diaz-Melean; J P Rodriguez-Escudero; Kashish Goel; Daniel Crusan; Abhiram Prasad; Ray W Squires; Randal J Thomas Journal: J Am Heart Assoc Date: 2017-10-11 Impact factor: 5.501